Community Research and Development Information Service - CORDIS

Results 1 - 10 of 207
Order by: Results/page:
12 3 4 5 6 7 8 9 10 > >| 
European Medical Information Framework
ID: 115372
Start date: 2013-01-01, End date: 2018-06-30
In response to the need to tackle increasingly complex medical research questions, a growing amount of human health data is being collected, either in routine Electronic Healthcare Record (EHR) databases, through research-driven cohort studies, in biobanks or related efforts....
Programme: FP7-JTI
Record Number: 203707
Last updated on: 2017-11-22
Intelligent Assessment of Pharmaceutical in the Environment
ID: 115735
Start date: 2015-01-01, End date: 2018-12-31
Active pharmaceutical ingredients (APIs) can be released to the natural environment during the manufacturing process, following use by patients or when unused medicines are disposed of. As APIs are biologically active compounds concerns have been raised about the potential ef...
Programme: FP7-JTI
Record Number: 203722
Last updated on: 2017-11-22
Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes
ID: 115010
Start date: 2009-10-01, End date: 2015-09-30
Rationale The inability of pre-clinical studies to predict clinical efficacy is a major bottleneck in drug development. In severe asthma this bottleneck results from: a lack of useful and validated biomarkers, underperforming pre-clinical models, inadequate and incomplete sub...
Programme: FP7-JTI
Record Number: 203682
Last updated on: 2017-11-22
Pharmaceutical Medicine Training Programme
ID: 115013
Start date: 2009-05-01, End date: 2014-04-30
"The proposed Pharmaceutical Medicine Training Programme provides a comprehensive solution for the complex needs of integrated drug development for all professionals involved, incl. physicians, pharmaceutical scientists,biologists, biometricians, health economists, and safety...
Programme: FP7-JTI
Record Number: 203685
Last updated on: 2017-11-21
SAFER AND FASTER EVIDENCE-BASED TRANSLATION
ID: 115003
Start date: 2009-06-15, End date: 2015-06-14
The public-private consortium composed of complementary SMEs, academic and clinical centers of excellence and EMEA as partner proposes SAFE-T (Safer And Easter Evidence-based Iranslation) project for the establishment of a biomarker (BM) qualification process and its validati...
Programme: FP7-JTI
Record Number: 203675
Last updated on: 2017-11-21
European Prevention of Alzheimer’s Dementia Consortium
ID: 115736
Start date: 2015-01-01, End date: 2019-12-31
Background: The secondary prevention of Alzheimer’s dementia (AD) is achievable if we can identify individuals at risk of disease progression defined by biomarker evidence of AD pathology and no or only minimal clinical symptoms and engage them in a standing adaptive clinical...
Programme: FP7-JTI
Record Number: 203723
Last updated on: 2017-11-20
Accelerated Development of Vaccine benefit-risk  Collaboration in Europe
ID: 115557
Start date: 2013-10-01, End date: 2018-09-30
Aim: The ADVANCE vision is focused on Timely and Best Evidence on Vaccine Effects. Our mission is to establish a best practice framework to rapidly provide robust data on vaccine benefits and risks to support accelerated decision-making. Approach: To achieve this vision throu...
Programme: FP7-JTI
Record Number: 203713
Last updated on: 2017-11-20
Improving the Knowledge in Hydrogen and Fuel Cell Technology for Technicians and Workers
ID: 621222
Start date: 2014-09-01, End date: 2018-02-28
KnowHY aims to provide the FC&H2 sector with a training offer for technicians and workers featuring quality in contents, accessibility in format and language, practicality for the targeted audience, ease of scalability and update, and at competitive costs which make the train...
Programme: FP7-JTI
Record Number: 192342
Last updated on: 2017-11-20
European Gram Negative Antibacterial Engine
ID: 115583
Start date: 2014-02-01, End date: 2020-01-31
The intensive use and misuse of antibiotics has resulted in some level of antibiotic resistance in essentially all human bacterial pathogens. There is a growing concern that the loss of therapeutic options will present us with a post-antibiotic era where present and future me...
Programme: FP7-JTI
Record Number: 203716
Last updated on: 2017-11-20
Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk
ID: 115303
Start date: 2012-03-01, End date: 2018-02-28
The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines. ABIRISK will involve many of the European leaders in rheumatology, gastroenterology, hemophilia...
Programme: FP7-JTI
Record Number: 203697
Last updated on: 2017-11-20
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-11-24
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top